Wegovy weight-loss pill goes on sale on UK high street and online pharmacies

Thousands of people begin receiving their first deliveries of once-a-day medication made by Novo Nordisk

A once-a-day Wegovy weight-loss pill has gone on sale at high street and online pharmacies in the UK, but is not yet available on the NHS.

Thousands of people began receiving their first deliveries of the pill, made by the Danish drugmaker Novo Nordisk, on Monday. It contains the same active GLP-1 ingredient as the Wegovy jab, semaglutide, and is similarly effective, according to studies.

Continue reading...

Weight-loss drug users save more than £400 a year on food as take-up triples

Research suggests households that include a GLP-1 user collectively spent £780m less on grocery bills

Weight-loss drugs are saving users’ households more than £400 a year on grocery bills, according to a survey, which found use of GLP-1s has nearly tripled in the past two years to 1.9 million adults.

More than 6.3% of households in Great Britain now include at least one GLP-1 user, according to the research by Worldpanel by Numerator. This marks a sharp rise from 4.1% of households in 2025 and 2.3% in 2024.

Continue reading...

Weight-loss drugs may prevent thousands of knee replacements, study suggests

Patients with knee arthritis who took medications for at least three years at reduced risk of needing surgery

Taking weight-loss drugs for at least three years could prevent thousands of knee replacements a year, research suggests.

Globally, more than 500 million people have osteoarthritis. Knee arthritis is the most common form, affecting about 14 million people in the US and more than 5 million in the UK. Many will require knee surgery. In the UK more than 120,000 knee replacements are carried out every year.

Continue reading...

What are peptides, are they safe and is there evidence to back up the hype?

Influencers and athletes are among those claiming substances can help with injury repair, weight loss and angi-ageing

From influencers to athletes, high-profile figures are hailing peptides as the route to wellness, claiming they help with injury repair, weight loss, anti-ageing and mood. We take a look at what these substances are, and the murky industry surrounding them.

Continue reading...

Medicines watchdog to investigate UK peptide clinics over health claims

Exclusive: Guardian investigation finds several clinics making potentially unlawful claims about benefits of unregulated therapies

The medicines regulator is investigating whether UK clinics are breaking the law by making claims about the benefits of unregulated, experimental peptide therapies, the Guardian can reveal.

Interest in experimental peptides has boomed in recent years. The substances are delivered by injection and are touted by sellers, influencers and even some medics as aiding everything from anti-ageing to recovery from injury.

Continue reading...

Weight-loss drugs could prevent fatal complications from heart attacks, UK study finds

Latest research based on animal model trials shows GLP-1 drugs may prevent problem of ‘no-reflow’ in recovery

Weight-loss drugs could help people who have had a heart attack avoid suffering potentially fatal complications afterwards, research has found.

Drugs such as Ozempic and Wegovy reduce the risk of the tissue damage that affects up to half of the 100,000 people a year in the UK who suffer a heart attack, according to the study.

Continue reading...